Mesenteric clearance of 5-fluorouracil in anesthetized rats.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J D Huang.
Explore the source record for details and available documents.
The pharmacokinetic response of theophylline following the oral administration of activated charcoal was investigated in rabbits. Rabbits were continuously infused with a theophylline solution at a rate of 2.12 mg/h. At the fourth hour of theophylline infusion, 20 g of activated charcoal was administered by intubation to the rabbit (n = 12). The concentration of theophylline in serum gradually decreased after the charcoal treatment. The magnitude of the change in theophylline concentration induced by charcoal varied among animals. By comparing the steady-state theophylline concentration in the control and treated animals, the total body clearance was found to increase from 94.4 +/- 7.5 to 210 +/- 27 mL/h/kg (mean +/- SE). The rate of change of theophylline concentration in serum following charcoal treatment was fitted with a simulation curve by assuming a stepwise increase in clearance immediately following the charcoal treatment. The results indicated that activated charcoal exerted its maximum effect in increasing theophylline clearance immediately after its administration.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The pharmacokinetics of 5-fluorouracil (5-FU) was investigated in tumor-free anesthetized rats. Blood samples in the carotid artery and in the right atrium were sampled by cannulation during the steady-state infusion of 5-FU. Serum and blood samples were assayed by HPLC. After comparing the steady-state concentration of 5-FU in the right carotid artery with that in the right atrium, it was concluded that there was no pulmonary elimination of 5-FU in the anesthetized rat.
The effect of changing the protein binding of S-disopyramide, a compound that is highly extracted by the liver on its hepatic clearance in rabbits is described. Using indocyanine green clearance as a means of measuring hepatic blood flow, qualitative changes were observed which are in agreement with the results predicted by both the 'parallel tube' and the 'well-stirred' models. However, neither model alone could explain the quantitative changes. Suggestions are put forward to explain these results.
For a drug with concentration-dependent serum protein binding, the unbound fraction of drug decreases during the drug elimination process. The clearance of the drug at a given blood flow rate is lower than would be expected from the observed unbound fraction in venous blood from a noneliminating organ. Based on both the "well-stirred" and "parallel tube" models, simulations demonstrated that consideration of concentration-dependent binding during drug elimination is important when the intrinsic clearance is higher than the blood flow and when the unbound drug concentration is much greater than the dissociation equilibrium constant of the binding complex.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Both R- and S-disopyramide prolong the QRS interval of the electrocardiogram in the rabbit. R-disopyramide is more potent than S-disopyramide at high concentrations (greater than 6 micrograms/ml), but shows similar potency at low concentrations (less than 6 micrograms/ml). R-disopyramide shows an estimated intermediate hepatic extraction ratio with a plasma clearance of 31.0 +/- 3.2 ml/min/kg that is only to a small degree concentration-dependent. S-disopyramide plasma clearance, on the other hand, is highly concentration-dependent, with a value larger than 50 ml/min/kg at concentrations below 4 micrograms/ml, that decreases to a value of approximately 30 ml/min/kg at 16 micrograms/ml. No differences in the binding of R- and S-disopyramide to rabbit serum or rabbit serum spiked with human alpha 1-acid glycoprotein were found.
The influence of altered serum protein binding on the pharmacologic response to R- and S-disopyramide was studied in the rabbit. Binding changes of disopyramide were achieved by the injection of human glycoprotein fraction VI. During constant infusion of R-disopyramide, the glycoprotein injection increased the total drug concentration in serum at steady state, while the unbound concentration was unaltered. The glycoprotein injection, however, decreased the unbound concentration and increased the total concentration during the steady-state infusion of S-disopyramide. In both experiments, the measured pharmacological response (delta QRS duration) reflected the change in the unbound drug concentration.
Quinidine shows two-compartment characteristics in rabbits with a terminal half-life of 67 min for total drug and 58 min for unbound drug. Statistically, the values are not significantly different from each other (p greater than 0.05). The clearances for total and unbound drug are 52 and 464 ml/min/kg, respectively, and the total and unbound apparent volumes of distribution at steady state are 4.2 and 27.3 liters/kg, respectively. The unbound clearance and unbound apparent volume of distribution were inversely related to the unbound fraction of quinidine in plasma. The total clearance and apparent volume of distribution showed no relationship to the binding. Approximately 0.5% of the dose was excreted as unchanged quinidine. Six identifiable metabolites were found in the urine, accounting for approximately 14% of the dose. Two unknown metabolites were also observed in the urine. With the exception of 2'-quinidinone, these metabolites were formed in the rate-limiting step in the metabolite kinetics. The quinidine unbound fraction ranged from 0.06 to 0.23 in the eight rabbits studied. The binding of the metabolites was less pronounced, and only 3-hydroxyquinidine showed a significant correlation with quinidine binding.
Explore the source record for details and available documents.
This study was undertaken to determine whether pharmacologic response to disopyramide is related to unbound or to total plasma concentration. Pharmacologic response, measured as changes in QRS duration of the EKG, was determined in rabbits at various steady-state concentrations of disopyramide under normal and altered plasma protein binding conditions. Plasma protein binding was increased by injection of 40 mg/kg of human glycoprotein fraction VI. The concentration-response curve for total concentration was displaced toward higher concentrations after increasing the plasma protein binding of disopyramide. The concentration-response curves obtained for unbound drug with and without the increased binding were superimposable. The displacement of the concentration-response curve for total drug was identical to the increase in concentration of the bound drug in plasma. These results demonstrate that the unbound concentrations of disopyramide in plasma are a better measure of the pharmacologic response than is the total plasma concentration.
Mathematical relationships describing the delivery of drug to a target organ after intra-arterial, intravenous, and oral administration are presented. This discussion clearly demonstrates that administration into a blood vessel leading to the target organ often is superior to intravenous administration. However, this superiority is not clear from traditional plasma concentration monitoring data.
The oral administration of etoposide has erratic absorption and low bioavailability. P-glycoprotein (Pgp) located in the intestinal brush-border membrane may pump out orally absorbed etoposide and thus decrease etoposide's absorption. Since flavonoids are abundant in food, we speculated that the common natural rodent diet may contain some flavonoid-related constituents which influence etoposide absorption. We therefore compared the absorption of etoposide's in the everted gut sacs of rats pretreated for 30 minutes with two different diets, natural rodent diet or artificial rodent diet. The effect of quercetin, one of the plant derived flavonoids with Pgp modulating activity, on etoposide's absorption was also compared. The addition of natural rodent diet or quercetin increased etoposide's absorption in everted sacs of jejunum or ileum, in comparison to those added with artificial rodent diet. The enhancing effect of quercetin was compatible with the effect of natural rodent diet in the jejunum and was higher in the ileum. These in vitro data supported the hypothesis that certain dietary components, possibly flavonoid-related compounds, may influence Pgp's function in intestine and thus increase etoposide's absorption. However, when fed with natural rodent diet for one week, a lower enhancing effect on absorption was observed. This may be due to the metabolism of the ingredients with modulating activity to their inactive forms, thus reducing the effect of natural rodent diet on etoposide absorption. The results proved that feeding rats with natural or artificial rodent diet had no obvious effect on etoposide absorption in vivo.
Enantioselectivity of esterases, contained in 9,000g supernatant fraction (S9) prepared from homogenate of small intestinal mucosa of male Sprague-Dawley rats and the subsequent 105,000g supernatant (cytosol) and pellet (microsomes) prepared from S9, was studied using racemic oxazepam 3-acetate (rac-OXA) as the substrate. Esterases in S9 were enantioselective in hydrolyzing either S-OXA or R-OXA, depending on a particular subcellular preparation. Cytosolic and microsomal esterases had opposite enantioselectivity and selectively hydrolyzed S-OXA and R-OXA, respectively. Enantioselectivity of esterases solubilized from microsomes with Triton X-100 (0.1%, w/v) was identical to that of the membrane-bound microsomal esterases. Cytosolic esterases were more sensitive to temperature than either solubilized or membrane-bound microsomal esterases. In the presence of paraoxon (1 microM), the esterases selective toward R-OXA in both microsomes and S9 were completely inhibited, whereas the esterases selective toward S-OXA in cytosol were inhibited by approximately 6%. These results indicate that cytosolic and microsomal esterases in rat small intestinal mucosa are distinctly different enzymes, with opposite enantioselectivity in the hydrolysis of rac-OXA.
P-glycoprotein (P-gp) actively pumps out a number of anticancer drugs, such as epirubicin, from tumor cells. P-gp is also expressed in the small intestine under normal physiological conditions. Inhibition of intestinal P-gp function using MDR reversing agents may enhance the oral bioavailability of some chemotherapeutic agents. Human colon adenocarcinoma (Caco-2) cell line expresses many characteristics of differentiated cells of the normal small intestine. Using Caco-2 as an in vitro intestinal model, the overall goal of the present study was to evaluate the MDR-reversing effects of some commonly used nonabsorptive pharmaceutical surfactants, such as Tween 20, Tween 80 and acacia on the intracellular accumulation of epirubicin by flow cytometry. Tween 20, Tween 80 or acacia all significantly increased intracellular accumulation of epirubicin with the highest enhancing effect for acacia and the lowest for Tween 20. Apart from progesterone, the enhancing effects of surfactants were better than those of non-surfactant MDR reversing agents such as verapamil, trifluoperazine and reserpine. In conclusion, our results demonstrate that progesterone, acacia, Tween 20 and Tween 80 are potent MDR modifiers of epirubicin in Caco-2 at concentrations that could be achieved in vivo. Use of surfactants in excipients may increase the intestinal absorption of some drugs through P-gp inhibition and thus improve drug bioavailability for P-gp substrate.